Astellas Pharma Inc ALPMY:Grey Market

*Data is delayed | Exchange | USD
Last | 11:15 AM EDT
9.39quote price arrow down-0.10 (-1.05%)
Volume
77,651
52 week range
9.15 - 16.91
Loading...
  • Open9.39
  • Day High9.41
  • Day Low9.37
  • Prev Close9.49
  • 52 Week High16.91
  • 52 Week High Date05/22/23
  • 52 Week Low9.15
  • 52 Week Low Date04/16/24

Key Stats

  • Market Cap17,174.72M
  • Shares Out1,792.99M
  • 10 Day Average Volume580,805.78
  • Dividend0.45
  • Dividend Yield4.82%
  • Beta-
  • YTD % Change-21.09

KEY STATS

  • Open9.39
  • Day High9.41
  • Day Low9.37
  • Prev Close9.49
  • 52 Week High16.91
  • 52 Week High Date05/22/23
  • 52 Week Low9.15
  • 52 Week Low Date04/16/24
  • Market Cap17,174.72M
  • Shares Out1,792.99M
  • 10 Day Average Volume580,805.78
  • Dividend0.45
  • Dividend Yield4.82%
  • Beta-
  • YTD % Change-21.09

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/25/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Astellas Pharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Kenji Yasukawa
Chairman of the Board, Chairman of the Board of Directors, Representative Director
Naoki Okamura
President, Chief Executive Officer, Representative Director
Katsuyoshi Sugita
Vice President, Chief People Officer, Chief Ethics & Compliance Officer, Representative Director
Address
2-5-1, Nihombashihon-cho
Chuo-ku, TKY
103-8411
Japan